Pine Bridge Investments, L.P. Corcept Therapeutics Inc Transaction History

Pine Bridge Investments, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $29,544 - $34,656	1,378 New	1,378 $30,000
Q1 2020 May 14, 2020	SELL	$10.11 - $14.04 $582,305 - $808,661	-57,597 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$12.06 - $16.96 $458,617 - $644,954	-38,028 Reduced 39.77%	57,597 $697,000
Q3 2019 Nov 13, 2019	BUY	$10.41 - $14.66 $49,072 - $69,107	4,714 Added 5.19%	95,625 $1.35 Million
Q2 2019 Aug 13, 2019	BUY	$9.78 - $12.76 $637,616 - $831,900	65,196 Added 253.53%	90,911 $1.01 Million
Q1 2019 May 14, 2019	SELL	$10.03 - $15.71 $1,815 - $2,843	-181 Reduced 0.7%	25,715 $302,000
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $28,642 - $43,611	2,537 Added 10.86%	25,896 $345,000
Q3 2018 Nov 13, 2018	BUY	$12.27 - $15.65 $85,485 - $109,033	6,967 Added 42.5%	23,359 $327,000
Q2 2018 Aug 09, 2018	SELL	$15.3 - $19.69 $14,504 - $18,666	-948 Reduced 5.47%	16,392 $258,000
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $252,990 - $442,170	17,340 New	17,340 $285,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.